Profound Medical (TSX:PRN) said today that it pulled in a $13.2 million (C$17.4 million) funding round that includes an over-allotment option that could bring in another $2 million (C$2.6 million). Led by GMP Securities, the syndicate of underwriters agreed to buy 15.82 million shares at about 84¢ (C$1.10) apiece, with an optional over-allotment of 2.373 million shares for the 30 […]
Profound Medical Inc.
Profound Medical moves Plymale to COO, taps ex-Novadaq CEO Menawat| Personnel Moves August 16, 2016
Profound Medical moves Plymale to COO, taps ex-Novadaq CEO Menawat Profound Medical said yesterday it is transitioning its current CEO Steven Plymale to the position of chief operating officer and picking up former Novadaq CEO Arun Menawat to take over the corner office. Menawat has held a position as a board member with Profound […]
Philips and Profound Medical extend ablation tech deal
Royal Philips (NYSE:PHG) said it extended its deal with Profound Medical to include a sales and marketing agreement to promote Profounds’ Tulsa-Pro ultrasound ablation system. Profounds Tulsa system allows for a minimally invasive, whole-gland ablation of the prostate, which will be guided by Philips MRI machines, the companies said. “Our agreement with Philips will enable us to […]
Profound Medical wins CE Mark for Tulsa-Pro ablation device
Profound Medical said today it won CE Mark approval in the European Union for its Tulsa-Pro ablation device designed to treat prostate cancer. The Toronto-based company’s system allows for a minimally invasive, whole-gland ablation of the prostate, guided by magnetic resonance imaging machines, the company said. “Our innovation and passion for this unique therapy has […]
EnteroMedics names ex-Lanx chief Gladney as CEO | Personnel Moves
EnteroMedics (NSDQ:ETRM) said it named Dan Gladney, the former chief executive who led Lanx to an acquisition by Biomet, to be its new CEO effective Nov. 16. St. Paul, Minn.-based EnteroMedics said chairman, president & CEO Mark Knudson will become executive chairman when Gladney takes over the corner office until Jan. 1, 2016, when he will […]
Philips, Profound Medical ink deal
Royal Philips (NYSE:PHG) said it signed a deal with Profound Medical to use Profound’s proprietary transurethral ultrasound ablation technology to treat prostate cancer patients in conjunction with Philips’ Ingenia and Achieva 3 tesla MRI systems. Profounds ‘Tulsa’ system allows for a minimally invasive, whole-gland ablation of the prostate, which will be guided by Philips MRI machines, […]
BSX aims for double-digit earnings growth | Medtech Wall Street news for the week of May 4, 2015
CEO says SNN ‘working hard’ on acquisitions trail | The week in medtech M&A
Profound Medical goes public in reverse merger
Profound Medical yesterday said it’s slated to hit the public markets in Canada after a reverse merger, also revealing a $24 million private placement to fuel clinical trial work.
Ex-Stryker CFO Hartman wins CEO job at ConMed | Personnel Moves
Mazzo suspended at Versant Ventures after insider trading indictment | Personnel Moves
Versant Ventures and James Mazzo agreed that Mazzo will "suspend any activities" at the venture capital shop following his indictment last month on insider trading charges.